• HOME
  • ABOUT US
    • ABOUT THE COMPANY
    • THE TEAM
    • CHIEF EXECUTIVE OFFICER
    • CHIEF PHYSICIAN ADVISOR
    • CLINICAL NEUROSCIENCE
    • BIOTECHNOLOGY ADVISOR
    • COMPANY PRESIDENT
    • CHIEF FINANCIAL OFFICER
  • FORZA™
    • ABOUT FORZA™
    • THE STORY
    • THE SOURCE
    • THE PLAN
    • CALORIE RESTRICTION
    • VIRTUAL LIBRARY
  • REVIEWS
    • THE REVIEWS
    • IN LONG COVID
    • IN ALZHEIMER'S DISEASE
    • IN PARKINSON'S DISEASE
    • IN LEWY BODY DEMENTIA
    • IN MULTIPLE SCLEROSIS
    • IN DIABETES
    • IN LUPUS ERYTHEMATOSUS
    • IN SPINAL CORD INJURY
    • IN ARTHRITIS & PAIN
    • IN MIGRAINE & DEPRESSION
    • INFLAMMATION & INSOMNIA
  • WEBINARS
    • WEBINAR GALLERY
    • THE BIOLOGY OF AGING
    • ALZHEIMER'S DISEASE
    • PARKINSON'S DISEASE
    • DEPRESSION
    • FRONTOTEMPORAL DEMENTIAS
    • MULTIPLE SYSTEM ATROPHY
  • CONTACT US
  • More
    • HOME
    • ABOUT US
      • ABOUT THE COMPANY
      • THE TEAM
      • CHIEF EXECUTIVE OFFICER
      • CHIEF PHYSICIAN ADVISOR
      • CLINICAL NEUROSCIENCE
      • BIOTECHNOLOGY ADVISOR
      • COMPANY PRESIDENT
      • CHIEF FINANCIAL OFFICER
    • FORZA™
      • ABOUT FORZA™
      • THE STORY
      • THE SOURCE
      • THE PLAN
      • CALORIE RESTRICTION
      • VIRTUAL LIBRARY
    • REVIEWS
      • THE REVIEWS
      • IN LONG COVID
      • IN ALZHEIMER'S DISEASE
      • IN PARKINSON'S DISEASE
      • IN LEWY BODY DEMENTIA
      • IN MULTIPLE SCLEROSIS
      • IN DIABETES
      • IN LUPUS ERYTHEMATOSUS
      • IN SPINAL CORD INJURY
      • IN ARTHRITIS & PAIN
      • IN MIGRAINE & DEPRESSION
      • INFLAMMATION & INSOMNIA
    • WEBINARS
      • WEBINAR GALLERY
      • THE BIOLOGY OF AGING
      • ALZHEIMER'S DISEASE
      • PARKINSON'S DISEASE
      • DEPRESSION
      • FRONTOTEMPORAL DEMENTIAS
      • MULTIPLE SYSTEM ATROPHY
    • CONTACT US
  • HOME
  • ABOUT US
    • ABOUT THE COMPANY
    • THE TEAM
    • CHIEF EXECUTIVE OFFICER
    • CHIEF PHYSICIAN ADVISOR
    • CLINICAL NEUROSCIENCE
    • BIOTECHNOLOGY ADVISOR
    • COMPANY PRESIDENT
    • CHIEF FINANCIAL OFFICER
  • FORZA™
    • ABOUT FORZA™
    • THE STORY
    • THE SOURCE
    • THE PLAN
    • CALORIE RESTRICTION
    • VIRTUAL LIBRARY
  • REVIEWS
    • THE REVIEWS
    • IN LONG COVID
    • IN ALZHEIMER'S DISEASE
    • IN PARKINSON'S DISEASE
    • IN LEWY BODY DEMENTIA
    • IN MULTIPLE SCLEROSIS
    • IN DIABETES
    • IN LUPUS ERYTHEMATOSUS
    • IN SPINAL CORD INJURY
    • IN ARTHRITIS & PAIN
    • IN MIGRAINE & DEPRESSION
    • INFLAMMATION & INSOMNIA
  • WEBINARS
    • WEBINAR GALLERY
    • THE BIOLOGY OF AGING
    • ALZHEIMER'S DISEASE
    • PARKINSON'S DISEASE
    • DEPRESSION
    • FRONTOTEMPORAL DEMENTIAS
    • MULTIPLE SYSTEM ATROPHY
  • CONTACT US

THE TEAM

Our interdisciplinary team has grown to include esteemed physicians, leading scientists, and experienced executives whose combined knowledge and decades of experience give us a unique and multidimensional understanding of human health and the biology of life and allow the company to leverage its leadership in the industry with a tailored client-focused approach. 

#

CHIEF EXECUTIVE OFFICER

DR. BRUNO RUGGIERO, PH.D.

#

CHIEF PHYSICIAN ADVISOR

DR. WILLIAM BITHONEY, MD, FAAP

#

CLINICAL NEUROSCIENCE ADVISOR

DOUGLAS WATT, PH.D.

#

CHIEF BIOTECHNOLOGY ADVISOR

PROF. EDDO RUGINI, PH.D.

#

COMPANY PRESIDENT

VERONICA SATCHKOVA

#

CHIEF FINANCIAL OFFICER

DAVID RISTENPART

CONTACT US

ORDER FORZA™

OPPORTUNITIES

OPPORTUNITIES

Fill out the Contact form to order FORZA™ or to send us your questions.

OPPORTUNITIES

OPPORTUNITIES

OPPORTUNITIES

Inquire about our current investment opportunities and how to get involved.

COLLABORATION

OPPORTUNITIES

COLLABORATION

Reach out for business or scientific collaborations and partnerships.

Visit www.osmotin.com to learn more.

CONTACT US
  • HOME
  • CALORIE RESTRICTION
  • VIRTUAL LIBRARY

Copyright © 2024

9th Dimension Biotech, Inc.

All Rights Reserved.

This site uses cookies to offer you a better browsing experience

We use cookies to analyze website traffic and optimize user experience.
By accepting, you agree that your data will be aggregated with the data of all other users.

Accept